Product Images Dexilant

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Dexilant NDC 64764-175 by Takeda Pharmaceuticals America, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - dexilant 01

Chemical Structure - dexilant 01

Figure 1 - dexilant 02

Figure 1 - dexilant 02

This is a graph showing the plasma concentration in ng/mL over time (in hours) for two doses of DEXILANT (30mg and 60mg). The x-axis represents time from 0 to 24 hours in 4-hour intervals. The y-axis represents plasma concentration in ng/mL, ranging from 0 to 1200 ng/mL. The graph indicates that the plasma concentration of both doses of DEXILANT increases from 0 to peak shortly after 2 hours and then declines gradually over time.*

PRINCIPAL DISPLAY PANEL - 30 mg Capsule Bottle Label - dexilant 03

PRINCIPAL DISPLAY PANEL - 30 mg Capsule Bottle Label - dexilant 03

This is a medication that comes in a bottle with 30 capsules, each containing 30mg of dexlansoprazole, an enteric-coated granule. The bottle should not be accepted if the seal over the opening is broken or missing. The usual dosage is indicated on the package insert. The medication is kept at room temperature and can be stored between 15-30°C. The medication is distributed by Takeda Pharmaceuticals and comes with a medication guide for each patient. The product's NDC code is 64764-171-30 and its GTIN code is 0364764171308.*

PRINCIPAL DISPLAY PANEL - 60 mg Capsule Bottle Label - dexilant 04

PRINCIPAL DISPLAY PANEL - 60 mg Capsule Bottle Label - dexilant 04

This is a medication with NDC code 64764-175-30 containing 30 capsules each with 60 mg of dexlansoprazole as enteric-coated granules. It is a prescription-only drug that should not be accepted if the bottle opening seal is broken or missing. The dosage should be followed as per the package insert. It is manufactured and distributed by Takeda Pharmaceuticals America, Inc. The medication guide should be dispensed to the patient. The recommended storage temperature is 20 to 25°C (68 to 77°F) for delayed-release capsules. Inaccessible to non-English characters.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.